Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Alzheimer's Disease

  Free Subscription


Articles published in Ann Neurol

Retrieve available abstracts of 46 articles:
HTML format
Text format



Single Articles


    March 2018
  1. SHEIKH-BAHAEI N, Sajjadi SA, Manavaki R, McLean M, et al
    PET-guided MR Spectroscopy in Alzheimer's disease.
    Ann Neurol. 2018 Mar 8. doi: 10.1002/ana.25202.
    PubMed     Text format     Abstract available


    February 2018
  2. GOETZL EJ, Schwartz JB, Abner EL, Jicha GA, et al
    High complement levels in astrocyte-derived exosomes of Alzheimer's disease.
    Ann Neurol. 2018 Feb 6. doi: 10.1002/ana.25172.
    PubMed     Text format     Abstract available


  3. TAN CH, Desikan RS
    Interpreting Alzheimer's disease polygenic scores.
    Ann Neurol. 2018 Feb 2. doi: 10.1002/ana.25164.
    PubMed     Text format    


    January 2018
  4. DONG Y, Lagarde J, Xicota L, Corne H, et al
    Neutrophil hyperactivation correlates with Alzheimer's disease progression.
    Ann Neurol. 2018 Jan 25. doi: 10.1002/ana.25159.
    PubMed     Text format     Abstract available


  5. WHITWELL JL, Graff-Radford J, Tosakulwong N, Weigand SD, et al
    [(18) F]AV-1451 clustering of entorhinal and cortical uptake in Alzheimer's disease.
    Ann Neurol. 2018 Jan 11. doi: 10.1002/ana.25142.
    PubMed     Text format     Abstract available


    November 2017
  6. CHRISTOPHER L, Napolioni V, Khan RR, Han SS, et al
    A variant in PPP4R3A protects against Alzheimer-related metabolic decline.
    Ann Neurol. 2017 Nov 11. doi: 10.1002/ana.25094.
    PubMed     Text format     Abstract available


    October 2017
  7. VEMURI P, Lesnick TG, Przybelski SA, Knopman DS, et al
    Age, Vascular Health, and Alzheimer's disease Biomarkers in an Elderly Sample.
    Ann Neurol. 2017 Oct 10. doi: 10.1002/ana.25071.
    PubMed     Text format     Abstract available


    September 2017
  8. BOROS BD, Greathouse KM, Gentry EG, Curtis KA, et al
    Dendritic spines provide cognitive resilience against Alzheimer's disease.
    Ann Neurol. 2017 Sep 16. doi: 10.1002/ana.25049.
    PubMed     Text format     Abstract available


  9. TAN CH, Hyman BT, Tan JJX, Hess CP, et al
    Polygenic hazard scores in preclinical Alzheimer disease.
    Ann Neurol. 2017;82:484-488.
    PubMed     Text format     Abstract available


    August 2017
  10. IRWIN DJ, Lleo A, Xie SX, McMillan CT, et al
    Ante mortem cerebrospinal fluid tau levels correlate with postmortem tau pathology in frontotemporal lobar degeneration.
    Ann Neurol. 2017;82:247-258.
    PubMed     Text format     Abstract available


    July 2017
  11. ESCOTT-PRICE V, Myers AJ, Huentelman M, Hardy J, et al
    Polygenic Risk Score Analysis of Pathologically Confirmed Alzheimer's Disease.
    Ann Neurol. 2017 Jul 20. doi: 10.1002/ana.24999.
    PubMed     Text format     Abstract available


    June 2017
  12. VASSILAKI M, Christianson TJ, Mielke MM, Geda YE, et al
    Neuroimaging biomarkers and impaired olfaction in cognitively normal individuals.
    Ann Neurol. 2017;81:871-882.
    PubMed     Text format     Abstract available


    May 2017
  13. MARTISKAINEN H, Herukka SK, Stancakova A, Paananen J, et al
    Decreased plasma beta-amyloid in the Alzheimer's disease APP A673T variant carriers.
    Ann Neurol. 2017 May 26. doi: 10.1002/ana.24969.
    PubMed     Text format     Abstract available


  14. TIJMS BM, Bertens D, Slot RE, Gouw AA, et al
    Low normal cerebrospinal fluid Abeta42 levels predict clinical progression in nondemented subjects.
    Ann Neurol. 2017;81:749-753.
    PubMed     Text format     Abstract available


    April 2017
  15. MENG Y, Volpini M, Black S, Lozano AM, et al
    Focused ultrasound as a novel strategy for Alzheimer's disease therapeutics.
    Ann Neurol. 2017 Apr 10. doi: 10.1002/ana.24933.
    PubMed     Text format     Abstract available


  16. HANSEEUW BJ, Betensky RA, Schultz AP, Papp KV, et al
    Fluorodeoxyglucose metabolism associated with tau-amyloid interaction predicts memory decline.
    Ann Neurol. 2017;81:583-596.
    PubMed     Text format     Abstract available


  17. ABNER EL, Kryscio RJ, Schmitt FA, Fardo DW, et al
    Outcomes after diagnosis of mild cognitive impairment in a large autopsy series.
    Ann Neurol. 2017;81:549-559.
    PubMed     Text format     Abstract available


    March 2017
  18. SPINELLI EG, Mandelli ML, Miller ZA, Santos-Santos MA, et al
    Typical and atypical pathology in primary progressive aphasia variants.
    Ann Neurol. 2017;81:430-443.
    PubMed     Text format     Abstract available


    December 2016
  19. MARQUIE M, Normandin MD, Meltzer AC, Siao Tick Chong M, et al
    Pathologic correlations of [F-18]-AV-1451 imaging in non-Alzheimer tauopathies.
    Ann Neurol. 2016 Dec 20. doi: 10.1002/ana.24844.
    PubMed     Text format     Abstract available


    November 2016
  20. KANTARCI K, Lowe VJ, Boeve BF, Senjem ML, et al
    AV-1451 Tau and beta-Amyloid PET Imaging in Dementia with Lewy Bodies.
    Ann Neurol. 2016 Nov 18. doi: 10.1002/ana.24825.
    PubMed     Text format     Abstract available


    October 2016
  21. ALBERS AD, Asafu-Adjei J, Delaney MK, Kelly KE, et al
    Episodic Memory of Odors Stratifies Alzheimer Biomarkers in Normal Elderly.
    Ann Neurol. 2016 Oct 1. doi: 10.1002/ana.24792.
    PubMed     Text format     Abstract available


  22. VOSSEL KA, Ranasinghe KG, Beagle AJ, Mizuiri D, et al
    Incidence and Impact of Subclinical Epileptiform Activity in Alzheimer's Disease.
    Ann Neurol. 2016 Oct 1. doi: 10.1002/ana.24794.
    PubMed     Text format     Abstract available


    August 2016
  23. BAYKARA E, Gesierich B, Adam R, Tuladhar AM, et al
    A novel imaging marker for small vessel disease based on skeletonization of white matter tracts and diffusion histograms.
    Ann Neurol. 2016 Aug 12. doi: 10.1002/ana.24758.
    PubMed     Text format     Abstract available


    July 2016
  24. VLASSENKO AG, McCue L, Jasielec MS, Su Y, et al
    Imaging and cerebrospinal fluid biomarkers in early preclinical Alzheimer disease.
    Ann Neurol. 2016 Jul 11. doi: 10.1002/ana.24719.
    PubMed     Text format     Abstract available


  25. TIRABOSCHI P, Corso A, Guerra UP, Nobili F, et al
    123 I-FP-CIT SPECT and 123 I-MIBG myocardial scintigraphy in differentiating dementia with Lewy bodies from other dementias: a comparative study.
    Ann Neurol. 2016 Jul 11. doi: 10.1002/ana.24717.
    PubMed     Text format     Abstract available


    June 2016
  26. TAKEDA S, Commins C, DeVos SL, Nobuhara CK, et al
    Seed-competent HMW tau species accumulates in the cerebrospinal fluid of Alzheimer's disease mouse model and human patients.
    Ann Neurol. 2016 Jun 28. doi: 10.1002/ana.24716.
    PubMed     Text format     Abstract available


  27. CHO H, Choi JY, Hwang MS, Kim YJ, et al
    In vivo cortical spreading pattern of tau and amyloid in the Alzheimer's disease spectrum.
    Ann Neurol. 2016 Jun 20. doi: 10.1002/ana.24711.
    PubMed     Text format     Abstract available


  28. HOEKSTRA JG, Hipp MJ, Montine TJ, Kennedy SR, et al
    Mitochondrial DNA Mutations Increase in Early Stage Alzheimer's Disease and are Inconsistent with Oxidative Damage.
    Ann Neurol. 2016 Jun 17. doi: 10.1002/ana.24709.
    PubMed     Text format     Abstract available


  29. DI LORENZO F, Ponzo V, Bonni S, Motta C, et al
    LTP-like cortical plasticity is disrupted in Alzheimer's disease patients independently from age of onset.
    Ann Neurol. 2016 Jun 3. doi: 10.1002/ana.24695.
    PubMed     Text format     Abstract available


    March 2016
  30. LEE S, Viqar F, Zimmerman ME, Narkhede A, et al
    White matter hyperintensities are a core feature of Alzheimer's disease: Evidence from the Dominantly Inherited Alzheimer Network.
    Ann Neurol. 2016 Mar 26. doi: 10.1002/ana.24647.
    PubMed     Text format     Abstract available


    February 2016
  31. TRAYLOR M, Adib-Samii P, Harold D, Dichgans M, et al
    Shared genetic contribution to Ischaemic Stroke and Alzheimer's Disease.
    Ann Neurol. 2016 Feb 23. doi: 10.1002/ana.24621.
    PubMed     Text format     Abstract available


    October 2015
  32. LA MORGIA C, Ross-Cisneros FN, Koronyo Y, Hannibal J, et al
    Melanopsin retinal ganglion cell loss in Alzheimer's disease.
    Ann Neurol. 2015 Oct 27. doi: 10.1002/ana.24548.
    PubMed     Text format     Abstract available


  33. JOHNSON KA, Schultz A, Betensky RA, Becker JA, et al
    Tau PET imaging in aging and early Alzheimer's disease.
    Ann Neurol. 2015 Oct 27. doi: 10.1002/ana.24546.
    PubMed     Text format     Abstract available


  34. REPLOGLE JM, De Jager PL
    Reply: To PMID 25545807.
    Ann Neurol. 2015;78:659-60.
    PubMed     Text format    


    September 2015
  35. MARQUIE M, Normandin MD, Vanderburg CR, Costantino I, et al
    Validating novel tau PET tracer [F-18]-AV-1451 (T807) on postmortem brain tissue.
    Ann Neurol. 2015 Sep 7. doi: 10.1002/ana.24517.
    PubMed     Text format     Abstract available


    August 2015
  36. LIU G, Jiang Q, Xu A, Li K, et al
    REST rs3796529 variant does not confer susceptibility to Alzheimer's disease.
    Ann Neurol. 2015 Aug 18. doi: 10.1002/ana.24503.
    PubMed     Text format    


  37. WANG JL, Lim AS, Chiang WY, Hsieh WH, et al
    Suprachiasmatic neuron numbers and rest-activity circadian rhythms in older humans.
    Ann Neurol. 2015;78:317-22.
    PubMed     Text format     Abstract available


    July 2015
  38. JOSEPHS KA, Whitwell JL, Tosakulwong N, Weigand SD, et al
    TDP-43 and pathological subtype of Alzheimer's disease impact clinical features.
    Ann Neurol. 2015 Jul 29. doi: 10.1002/ana.24493.
    PubMed     Text format     Abstract available


  39. DOLS-ICARDO O, Vilaplana E, Sampedro F, Alcolea D, et al
    Effect of REST on brain metabolism in the Alzheimer's disease continuum.
    Ann Neurol. 2015 Jul 15. doi: 10.1002/ana.24484.
    PubMed     Text format    


  40. ALBIN RL, Fisher-Hubbard A, Shanmugasundaram K, Koeppe RA, et al
    Post-Mortem Evaluation of Amyloid-Dopamine Terminal PET Dementia Classifications.
    Ann Neurol. 2015 Jul 15. doi: 10.1002/ana.24481.
    PubMed     Text format     Abstract available


  41. VANDERHORST VG, Samardzic T, Saper CB, Anderson MP, et al
    alpha-Synuclein pathology accumulates in sacral spinal visceral sensory pathways.
    Ann Neurol. 2015;78:142-9.
    PubMed     Text format     Abstract available


    June 2015
  42. VARDARAJAN BN, Ghani M, Kahn A, Sheikh S, et al
    Rare coding mutations identified by sequencing of Alzheimer's disease GWAS loci.
    Ann Neurol. 2015 Jun 23. doi: 10.1002/ana.24466.
    PubMed     Text format     Abstract available


  43. PERROTIN A, Desgranges B, Landeau B, Mezenge F, et al
    Anosognosia in Alzheimer disease: Disconnection between memory and self networks.
    Ann Neurol. 2015 Jun 18. doi: 10.1002/ana.24462.
    PubMed     Text format     Abstract available


  44. LIU G
    No association of TREM1 rs6910730 and TREM2 rs7759295 with Alzheimer's disease.
    Ann Neurol. 2015 Jun 9. doi: 10.1002/ana.24458.
    PubMed     Text format    


    April 2015
  45. ZHOU Q, Wang M, Du Y, Zhang W, et al
    Inhibition of c-Jun N-terminal kinase activation reverses Alzheimer disease phenotypes in APPswe/PS1dE9 mice.
    Ann Neurol. 2015;77:637-54.
    PubMed     Text format     Abstract available


    February 2015
  46. MICHAILIDOU I, Willems JG, Kooi EJ, van Eden C, et al
    Complement C1q-C3 associated synaptic changes in multiple sclerosis hippocampus.
    Ann Neurol. 2015 Feb 27. doi: 10.1002/ana.24398.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: